Literature DB >> 21969782

Tc99m-MDP bone scintigraphy in Engelmann-Camurati disease.

Chidambaram Natrajan Balasubramanian Harisankar1, Koramadai Karuppuswamy Kamleshwaran, Anish Bhattacharya, Baljinder Singh, Sanjay Bhadada, Bhagwant Rai Mittal.   

Abstract

Engelmann-Camurati disease (ECD) is a rare bone disorder characterized by autosomal dominant inheritance. It usually presents in early childhood and is associated with symmetrical diaphyseal sclerosis. We report a 20-year-old female with scintigraphic findings characteristic of ECD. She was treated with corticosteroids and showed marked clinical improvement.

Entities:  

Keywords:  Bone scintigraphy; Engelmann-Camurati disease; progressive diaphyseal dysplasia

Year:  2011        PMID: 21969782      PMCID: PMC3180724          DOI: 10.4103/0972-3919.84615

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


INTRODUCTION

Engelmann-Camurati disease (ECD) is an autosomal dominant bone disorder caused by mutations in the TGF1 gene[1] and is characterized by progressive bilaterally symmetrical diaphyseal sclerosis of the long bones. It presents prenatally or early during childhood with severe deformities and dwarfism and is characterized by marked thickening of the cortices limited to the diaphyseal regions of tubular bones, occurring on both periosteal and endosteal surfaces.[2] It usually presents in young children with gait disturbance and limb pain and deformity. Autosomal dominant transmission has been noted.[3] Scintigraphically, ECD presents as an increased tracer uptake in the diaphyses of the long bones with sparing of the metaphyses and epiphyses, with corresponding sclerosing dysplastic changes in X-rays.[4-6] This pattern of involvement of the diaphyses with sparing of the metaphyses and epiphyses is characteristic of ECD.[7]

CASE REPORT

We report a 20-year-old female, who presented with generalized weakness, dull aching pain in the legs and difficulty in waking. Neurologic work up was within normal limits. Bone marrow examination, performed to exclude malignancy, revealed normal bone marrow. Bone scintigraphy was diagnostic of ECD [Figure 1]. She was treated with corticosteroids and physiotherapy and showed marked improvement clinically.
Figure 1

Whole body bone scintigraphy images taken 3 hours after intravenous injection of 20 mCi of 99m-Tc-Methylene diphosphonate show increased symmetrical tracer uptake in diaphyses of bilateral femurs and tibiae. Increased tracer uptake is also noted in the proximal humeri. Scoliosis is also noted

Whole body bone scintigraphy images taken 3 hours after intravenous injection of 20 mCi of 99m-Tc-Methylene diphosphonate show increased symmetrical tracer uptake in diaphyses of bilateral femurs and tibiae. Increased tracer uptake is also noted in the proximal humeri. Scoliosis is also noted
  7 in total

1.  Radionuclide bone scintigraphy in Engelmann-Camurati disease.

Authors:  D Narang; B Bharati; A Bhattacharya; B R Mittal
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

2.  Bone scintigraphy in Engelmann-Camurati disease.

Authors:  Alvaro De Bonilla Damiá; Cinta Calvo Morón; Pablo Antonio De la Riva Pérez; Teresa Cambil Molina; Manuela Molina Mora; Auxiliadora Fernández Fatou; Juan Castro Montaño
Journal:  Clin Nucl Med       Date:  2010-07       Impact factor: 7.794

3.  Camurati-Engelmann disease on a 99mTc-HMDP bone scan.

Authors:  Mitsuhiro Momose; Kunihiro Yoshida; Shin Yanagisawa; Masumi Kadoya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

4.  Camurati-Engelmann disease. Genetics and clinical manifestations with a review of the literature.

Authors:  R S Sparkes; C B Graham
Journal:  J Med Genet       Date:  1972-03       Impact factor: 6.318

5.  Progressive diaphyseal dysplasia (Engelmann's disease). Report of a sporadic case of the mild form.

Authors:  M D Fallon; M P Whyte; W A Murphy
Journal:  J Bone Joint Surg Am       Date:  1980-04       Impact factor: 5.284

6.  Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease).

Authors:  T Inaoka; N Shuke; J Sato; Y Ishikawa; K Takahashi; T Aburano; Y Makita
Journal:  Clin Nucl Med       Date:  2001-08       Impact factor: 7.794

7.  The first Korean case of Camurati-Engelmann disease (progressive diaphyseal dysplasia) confirmed by TGFB1 gene mutation analysis.

Authors:  Seo-Jin Park; Choon Sik Yoon; Hui-Wan Park; Jong Rak Choi; Jong Shin Chung; Kyung-A Lee
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.